Gabriel Jaime Echeverri

Gabriel Jaime Echeverri

Auto-generated profile, based on publicly available information

Gabriel Jaime Echeverri

Thomas E. Starzl Transplantation Institute, Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2014 in Xenotransplantation
Verified
Journal Article
Open access
PDF file
MEMohamed B. Ezzelarab
Mohamed B. Ezzelarab
BEBurcin Ekser
Burcin Ekser
AAAgnes Azimzadeh
Agnes Azimzadeh
CLChih Che Lin
Chih Che Lin
YZYuming Zhao
Yuming Zhao
DCDavid K. Cooper
David K. Cooper
Background: Dysregulation of coagulation is considered a major barrier against successful pig organ xenotransplantation in non‐human primates. Inflammation is known to promote activation of coagulation. The role of pro‐inflammatory factors as well as the relationship between inflammation and activation of coagulation in xenograft recipients is poorly understood.Methods: Baboons received kidney (n = 3), heart (n = 4), or artery patch (n = 8) xenografts from α1,3‐galactosyltransferase gene‐knockout (GTKO) pigs or GTKO pigs additionally transgenic for human complement‐regulatory protein CD46 (GTKO/CD46). Immunosuppression (IS) was based on either CTLA4Ig or anti‐CD154 costimulation blockade. Three artery patch recipients did not receive IS. Pro‐inflammatory cytokines, chemokines, and coagulation parameters were evaluated in the circulation after transplantation. In artery patch recipients, monocytes and dendritic cells (DC) were monitored in peripheral blood. Expression of tissue factor (TF) and CD40 on monocytes and DC were assessed by flow cytometry. C‐reactive protein (C‐RP) levels in the blood and C‐RP deposition in xenografts as well as native organs were evaluated. Baboon and pig C‐RP mRNA in heart and kidney xenografts were evaluated.Results: In heart and kidney xenograft recipients, the levels of INFγ, TNF‐α, IL‐12, and IL‐8 were not significantly higher after transplantation. However, MCP‐1 and IL‐6 levels were significantly higher after transplantation, particularly in kidney recipients. Elevated C‐RP levels preceded activation of coagulation in heart and kidney recipients, where high levels of C‐RP were maintained until the time of euthanasia in both heart and kidney recipients. In artery patch recipients, INFγ, TNF‐α, IL‐12, IL‐8, and MCP‐1 were elevated with no IS, while IL‐6 was not. With IS, INFγ, TNF‐α, IL‐12, IL‐8, and MCP‐1 were reduced, but IL‐6 was elevated. Elevated IL‐6 levels were observed as early as 2 weeks in artery patch recipients. While IS was associated with reduced thrombin activation, fibrinogen and C‐RP levels were increased when IS was given. There was a significant positive correlation between C‐RP, IL‐6, and fibrinogen levels. Additionally, absolute numbers of monocytes were significantly increased when IS was given, but not without IS. This was associated with increased CD40 and TF expression on CD14+ monocytes and lineageneg CD11c+ DC, with increased differentiation of the pro‐inflammatory CD14+ CD11c+ monocyte population. At the time of euthanasia, C‐RP deposition in kidney and heart xenografts, C‐RP positive cells in artery patch xenograft and native lungs were detected. Finally, high levels of both pig and baboon C‐RP mRNA were detected in heart and kidney xenografts.Conclusions: Inflammatory responses precede activation of coagulation after organ xenotransplantation. Early upregulation of C‐RP and IL‐6 levels may amplify activation of coagulation through upregulation of TF on innate immune cells. Prevention of systemic inflammation in xenograft recipients (SIXR) may be required to prevent dysregulation of coagulation and avoid excessive IS after xenotransplantation.

24 January 2010 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
BEBurcin Ekser
Burcin Ekser
CLC. Long
C. Long
GEG. J. Echeverri
G. J. Echeverri
HHH. Hara
H. Hara
MEM. Ezzelarab
M. Ezzelarab
BGB. Gridelli
B. Gridelli
A lack of deceased human donor livers leads to a significant mortality in patients with acute-on-chronic or acute (fulminant) liver failure or with primary nonfunction of an allograft. Genetically engineered pigs could provide livers that might bridge the patient to allotransplantation. Orthotopic liver transplantation in baboons using livers from α1,3-galactosyltransferase gene-knockout (GTKO) pigs (n = 2) or from GTKO pigs transgenic for CD46 (n = 8) were carried out with a clinically acceptable immunosuppressive regimen. Six of 10 baboons survived for 4–7 days. In all cases, liver function was adequate, as evidenced by tests of detoxification, protein synthesis, complement activity and coagulation parameters. The major problem that prevented more prolonged survival beyond 7 days was a profound thrombocytopenia that developed within 1 h after reperfusion, ultimately resulting in spontaneous hemorrhage at various sites. We postulate that this is associated with the expression of tissue factor on platelets after contact with pig endothelium, resulting in platelet and platelet-peripheral blood mononuclear cell(s) aggregation and deposition of aggregates in the liver graft, though we were unable to confirm this conclusively. If this problem can be resolved, we would anticipate that a pig liver could provide a period during which a patient in liver failure could be successfully bridged to allotransplantation.

25 June 2010 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
CLC. C. Lin
C. C. Lin
MEM. Ezzelarab
M. Ezzelarab
RSR. Shapiro
R. Shapiro
BEBurcin Ekser
Burcin Ekser
CLC. Long
C. Long
DCDavid Cooper
David Cooper
Consumptive coagulopathy (CC) remains a challenge in pig‐to‐primate organ xenotransplantation (Tx). This study investigated the role of tissue factor (TF) expression on circulating platelets and peripheral blood mononuclear cells (PBMCs). Baboons (n = 9) received a kidney graft from pigs that were either wild‐type (n = 2), α1,3‐galactosyltransferase gene‐knockout (GT‐KO; n = 1) or GT‐KO and transgenic for the complement‐regulatory protein, CD46 (GT‐KO/CD46, n = 6). In the baboon where the graft developed hyperacute rejection (n = 1), the platelets and PBMCs expressed TF within 4 h of Tx. In the remaining baboons, TF was detected on platelets on post‐Tx day 1. Subsequently, platelet‐leukocyte aggregation developed with formation of thrombin. In the six baboons with CC, TF was not detected on baboon PBMCs until CC was beginning to develop. Graft histopathology showed fibrin deposition and platelet aggregation (n = 6), but with only minor or no features indicating a humoral immune response (n = 3), and no macrophage, B or T cell infiltration (n = 6). Activation of platelets to express TF was associated with the initiation of CC, whereas TF expression on PBMCs was concomitant with the onset of CC, often in the relative absence of features of acute humoral xenograft rejection. Prevention of recipient platelet activation may be crucial for successful pig‐to‐primate kidney Tx.

1 October 2019 in Journal of Hepatology
Verified
Journal Article
Closed access
CTChristoph Tschuor
Christoph Tschuor
Alberto FerrareseAlberto Ferrarese
Alberto Ferrarese
CKChristoph Kuemmerli
Christoph Kuemmerli
PDPhilipp Dutkowski
Philipp Dutkowski
PBPatrizia Burra
Patrizia Burra
PKPhilipp Kron
Philipp Kron

1 September 2008 in Cell Transplantation
Verified
Journal Article
Open access
DWDirk J. Van Der Windt
Dirk J. Van Der Windt
GEGabriel J. Echeverri
Gabriel J. Echeverri
JIJan N. M. Ijzermans
Jan N. M. Ijzermans
DCDavid K. C. Cooper
David K. C. Cooper
Islet transplantation into the portal vein is the current clinical practice. However, it has now been recognized that this implantation site has several characteristics that can hamper islet engraftment and survival, such as low oxygen tension, an active innate immune system, and the provocation of an inflammatory response (IBMIR). These factors result in the loss of many transplanted islets, mainly during the first hours or days after transplantation, which could in part explain the necessity for the transplantation of islets from multiple pancreas donors to cure type 1 diabetes. This increases the burden on the limited pool of donor organs. Therefore, an alternative anatomical site for islet transplantation that offers maximum engraftment, efficacious use of produced insulin, and maximum patient safety is urgently needed. In this review, the experience with alternative sites for islet implantation in clinical and experimental models is discussed. Subcutaneous transplantation guarantees maximum patient safety and has become clinically applicable. Future improvements could be achieved with innovative designs for devices to induce neovascularization and protect the islets from cellular rejection. However, other sites, such as the omentum, offer drainage of produced insulin into the portal vein for direct utilization in the liver. The use of pigs would not only overcome the shortage of transplantable islets, but genetic modification could result in the expression of human genes, such as complement regulatory or “anticoagulation” genes in the islets to overcome some site-specific disadvantages. Eventually, the liver will most likely be replaced by a site that allows long-term survival of islets from a single donor to reverse type 1 diabetes.

15 October 2009 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
GEG. J. Echeverri
G. J. Echeverri
KMK. McGrath
K. McGrath
RBR. Bottino
R. Bottino
HHH. Hara
H. Hara
EDE. M. Dons
E. M. Dons
DCDavid Cooper
David Cooper
The results of transplantation of human donor islets into the portal vein (PV) in patients with diabetes are encouraging. However, there are complications, for example, hemorrhage, thrombosis and an immediate loss of islets through the ‘instant blood-mediated inflammatory reaction’ (IBMIR). The gastric submucosal space (GSMS) offers potential advantages. Islets were isolated from adult pigs. Recipient pigs were made diabetic by streptozotocin. Donor islets were injected into the GSMS through a laparotomy (Group 1A, n = 4) or endoscopically (Group 1B, n = 8) or into the PV through a laparotomy (Group 2, n = 3). The pigs were followed for a maximum of 28 days. Monitoring of C-peptide in Group 1 indicated that there was minimal immediate loss of islets whereas in Group 2 there was considerable loss from IBMIR. In Group 1, there were significant reductions in mean blood glucose and mean exogenous insulin requirement between pretransplantation and 20 days posttransplantation. In Group 2, there was no significant reduction in either parameter. Insulin-positive cells were seen in the GSMS in Group 1, but not in the liver in Group 2. Endoscopic gastric submucosal transplantation of islets (ENDO-STI) offers a minimally invasive and quick approach to islet transplantation, avoids IBMIR and warrants further exploration.